Riyadh
King Faisal Specialist Hospital & Research Centre (KFSHRC) and the University of Birmingham’s Bladder Cancer Research Centre (BCRC) have announced a five-year partnership to revolutionise bladder cancer diagnosis and monitoring. This partnership unites the expertise of KFSHRC’s Urology Department with BCRC’s research capabilities to advance non-invasive diagnostic tools using advanced liquid biopsy technology.
This project aims to bring cutting-edge molecular diagnostics to Saudi Arabia using a 23-gene panel to detect key genetic variations. Prof. Waleed Altaweel, Chairman of the Urology Department at KFSHRC and the Principal Investigator, commented: “Partnering with BCRC allows us to introduce innovative diagnostic methods that ease the burden on patients while improving healthcare outcomes. This collaboration supports our priorities by bridging geographic and technological divides and advancing cancer diagnostics across a diverse population.”
Beyond diagnostic innovation, this partnership is a knowledge exchange platform, enabling Saudi and UK research communities to collaborate closely, sharing methodologies, insights, and technological advancements in genomic diagnostics. Prof. Mohamed Alotaibi, a Co-Principal Investigator, highlighted, “This collaborative approach aligns with global healthcare goals, enhancing expertise and building capacity to tackle complex health challenges.”
Underpinning this partnership is a Material Transfer Agreement (MTA) that ensures secure, ethical exchanges of anonymised patient samples, enabling advanced genomic testing while maintaining strict data privacy. Dr. Raouf Seyam, Project facilitator, stated, “This collaboration offers an unprecedented opportunity to expand our research by incorporating diverse genetic data, ultimately contributing to globally relevant cancer care solutions. KFSHRC and BCRC are set to transform bladder cancer care by establishing new, accessible standards for patient-centred, non-invasive diagnostics.”
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world’s best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at [email protected]
